4.3 Article

MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells

Journal

ONCOTARGET
Volume 8, Issue 41, Pages 69797-69807

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.19267

Keywords

microRNA-34a (miR-34a); ionizing radiation; non-small cell lung cancer; cellular senescence; c-Myc

Funding

  1. NIH [GM103542, HL106451]
  2. South Carolina Clinical & Translational Research (SCTR) Institute (NIH/NCATS) [UL1TR000062]
  3. Cell & Molecular Imaging Shared Resource of Hollings Cancer Center at the Medical University of South Carolina [P30 CA138313]
  4. Shared Instrumentation Grant [USPHS S10 OD018113]

Ask authors/readers for more resources

MicroRNAs (miRNAs) are a new class of gene expression regulators that have been implicated in tumorigenesis and modulation of the responses to cancer treatment including that of human non-small cell lung cancer (NSCLC). However, the role of miR-34a in ionizing radiation (IR)-induced senescence in NSCLC cells remains poorly understood. Here we report that IR-induced premature senescence correlates with upregulation of miR-34a expression in NSCLC cells. Ectopic overexpression of miR-34a by transfection with synthetic miR-34a mimics markedly enhances IR-induced senescence, whereas inhibition of miR-34a by transfection with a synthetic miR-34a inhibitor attenuates IR-induced senescence. Clonogenic assays reveal that treatment with miR-34a mimics augments IR-induced cell killing in human NSCLC cells. Mechanistically, we found that the senescence-promoting effect of miR-34a is associated with a dramatic down-regulation of c-Myc (Myc) expression, suggesting that miR-34a may promote IR-induced senescence via targeting Myc. In agreement with this suggestion, knockdown of Myc expression by RNAi recapitulates the senescence-promoting effect of miR-34a and enhances IR-induced cell killing in NSCLC cells. Collectively, these results demonstrate a previously unrecognized role for miR-34a in modulating IR-induced senescence in human NSCLC cells and suggest that pharmacological intervention of miR-34a expression may represent a new therapeutic strategy for improving the efficacy of lung cancer radiotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available